Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club

Inward Investment
Return to: PBR Home | Inward Investment

Inward Investment

Recipharm to buy Corvette Pharmaceutical Services for $160m By PBR Staff Writer
Swedish contract development and manufacturing organisation Recipharm has agreed to purchase Milan based Corvette Pharmaceutical Services Group (Corvette) from Italian private equity group LBO Italia Investimenti.
Inward Investment > News
Novartis agrees to acquire 15% stake in Gamida Cell By PBR Staff Writer
Swiss drugmaker Novartis Pharma has signed an agreement to acquire 15% stake in Gamida Cell for $35m.
Inward Investment > News Amgen to buy Onyx Pharmaceuticals for $10.4bn By PBR Staff Writer
Biotechnology company Amgen has reached a deal to buy all outstanding shares of California-based Onyx Pharmaceuticals for $125 per share in cash.
Inward Investment > News
See more Inward Investment news

Latest Inward Investment News and Insight

View all Inward Investment news or find news targeted to your interests
Johnson & Johnson completes purchase of Aragon Pharmaceuticals
By PBR Staff Writer
Johnson & Johnson has completed the acquisition of Aragon Pharmaceuticals, a pharmaceutical discovery and development company focused on drugs to hormonally-driven cancers.
Inward Investment > News
Breckenridge to acquire certain assets of Cypress Pharmaceuticals
By PBR Staff Writer
Pharmaceutical marketing, research and development company Breckenridge Pharmaceutical has signed a deal to acquire certain assets of Pernix Therapeutics' subsidiary, Cypress Pharmaceuticals, for $30m.
Inward Investment > News
Actavis takes over Palau Pharma's Albaconazole antifungal agent
By PBR Staff Writer
Actavis Specialty Brands has purchased worldwide rights for Palau Pharma's Albaconazole antifungal agent indicated for the treatment of vulvo-vaginal candidiasis, onychomycosis and other antifungal applications.
Inward Investment > News
Cubist to acquire Optimer Pharmaceuticals and Trius Therapeutics
By PBR Staff Writer
Cubist Pharmaceuticals has entered into two separate agreements to acquire Optimer Pharmaceuticals and Trius Therapeutics, as part of the company's Building Blocks of Growth strategy to strengthen its presence in acute care and hospital environments.
Inward Investment > News
Pfizer plans internal classification of commercial businesses
By PBR Staff Writer
Pfizer is planning for internal classification of its commercial operations into three business segments, which will include developed and emerging markets, in an effort to deliver value to consumers and patients.
Inward Investment > News
Perrigo proposes to acquire Elan for $8.6bn
By PBR Staff Writer
Global healthcare products provider Perrigo Company and Elan have entered into a definitive agreement, under which the latter will be acquired by a new holding company in Ireland, New Perrigo, in a $8.6bn cash and stock transaction.
Inward Investment > News
GSK postpones plan to increase stake in Nigerian arm
By PBR Staff Writer
UK-based GlaxoSmithKline (GSK) has postponed plans to increase its stake from 46.4% to 75% in GlaxoSmithKline Consumer Nigeria (GSK Nigeria), proposed under a scheme of arrangement.
Inward Investment > News
Spectrum Pharmaceuticals to buy Talon Therapeutics
By PBR Staff Writer
Biotechnology company Spectrum Pharmaceuticals (SPPI) has entered into an agreement to acquire California-based biopharmaceutical firm Talon Therapeutics (TLON).
Inward Investment > News
Cipla completes acquisition of Cipla Medpro South Africa for $456.43m
By PBR Staff Writer
Indian based pharmaceutical company Cipla has completed the acquisition of Cipla Medpro South Africa for a consideration of ZAR4.507bn ($456.43m).
Inward Investment > News
Mitsubishi Tanabe Pharma plans to purchase Medicago for $357m
By PBR Staff Writer
Japanese Mitsubishi Tanabe Pharma (MTPC) has agreed to acquire Medicago, a biopharma company that develops vaccines, in a deal valued at nearly $357m.
Inward Investment > News
View all Inward Investment news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250